MCID: INT002
MIFTS: 54

Intermittent Claudication malady

Cardiovascular diseases category

Summaries for Intermittent Claudication

About this section


Wikipedia:64 Intermittent claudication (Latin: claudicatio intermittens) is a clinical diagnosis given for muscle... more...

MalaCards based summary: Intermittent Claudication, also known as intermittent claudication nos, is related to peripheral vascular disease and ischemia. An important gene associated with Intermittent Claudication is SELP (selectin P (granule membrane protein 140kDa, antigen CD62)), and among its related pathways are Cell adhesion Plasmin signaling and Complement and coagulation cascades. The drugs pentoxifylline and cilostazol and the compounds sarpogrelate hydrochloride and sarpogrelate have been mentioned in the context of this disorder. Affiliated tissues include testes, endothelial and bone, and related mouse phenotypes are skeleton and hematopoietic system.

Aliases & Classifications for Intermittent Claudication

About this section

Intermittent Claudication, Aliases & Descriptions:

Name: Intermittent Claudication 31 9 11 44 61
Intermittent Claudication Nos 9
 
Charcot's Syndrome 9


Classifications:

Malacards categories (disease lists): (See all malacards categories)
Anatomical: Cardiovascular diseases


External Ids:

Disease Ontology9 DOID:3669
MeSH34 D007383

Related Diseases for Intermittent Claudication

About this section

Diseases related to Intermittent Claudication via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 76)
idRelated DiseaseScoreTop Affiliating Genes
1peripheral vascular disease30.7VWF, SELP
2ischemia30.5SELP, FGA, FGF2
3vascular disease30.3VWF, SELP, FGF2
4diabetes mellitus30.1FGA, SELP, VWF
5atherosclerosis30.0FGF2, FGA, SELP, VWF
6myocardial infarction29.9VWF, SELP, HTR2A, FGA
7artery disease10.9
8peripheral artery disease10.9
9endotheliitis10.7
10blindness10.6
11spinal stenosis10.6
12limb ischemia10.5
13cystic adventitial disease10.5
14critical limb ischemia10.5
15arteriosclerosis10.4
16aneurysm10.4
17coronary thrombosis10.3VWF
18hypertension10.3
19abdominal aortic aneurysm10.3
20arteriosclerosis obliterans10.3
21aortic aneurysm10.3
22fibromuscular dysplasia10.3
23blood platelet disease10.2VWF, SELP
24von willebrand's disease10.2SELP, VWF
25factor viii deficiency10.1VWF, SELP
26thrombotic thrombocytopenic purpura, acquired10.1VWF, SELP
27angina pectoris10.1
28arteriovenous fistula10.1
29obesity10.1
30pseudoxanthoma elasticum10.1
31spondylosis10.1
32carotid stenosis10.1
33systolic heart failure10.1
34neuronitis10.1
35noonan syndrome10.1
36amyloidosis10.1
37carotid artery disease10.1
38cervicitis10.1
39compartment syndrome10.1
40lipoma10.1
41lymphangioma10.1
42neurofibroma10.1
43pneumonia10.1
44proteinuria10.1
45hypoxia10.1
46insulin resistance10.1
47hemorrhagic thrombocythemia10.1SELP, VWF
48mitral valve stenosis10.1SELP, FGA
49antiphospholipid syndrome10.1VWF, SELP
50proliferative diabetic retinopathy10.1FGF2, SELP

Graphical network of the top 20 diseases related to Intermittent Claudication:



Diseases related to intermittent claudication

Symptoms for Intermittent Claudication

About this section

Drugs & Therapeutics for Intermittent Claudication

About this section

Drug clinical trials:

Search ClinicalTrials for Intermittent Claudication

Search NIH Clinical Center for Intermittent Claudication

Inferred drug relations via UMLS61/NDF-RT40:

Cell-based therapeutics:


LifeMap Discovery
The database of embryonic development, stem cell research and regenerative medicine
Read about Intermittent Claudication cell therapies at LifeMap Discovery.

Genetic Tests for Intermittent Claudication

About this section

Anatomical Context for Intermittent Claudication

About this section

MalaCards organs/tissues related to Intermittent Claudication:

32
Testes, Endothelial, Bone, Heart, Skeletal muscle, Brain, Spinal cord

LifeMap Discovery
The database of embryonic development, stem cell research and regenerative medicine

Cells/anatomical compartments in embryo or adult related to Intermittent Claudication:
id TissueAnatomical CompartmentCell Relevance
1 PlacentaChorionic VillusChorionic Mesenchymal Stromal Cells Potential therapeutic candidate

Animal Models for Intermittent Claudication or affiliated genes

About this section

MGI Mouse Phenotypes related to Intermittent Claudication:

36
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053908.2FGF2, FGA, HTR2A, SELP
2MP:00053978.1FGF2, FGA, SELP, VWF
3MP:00053857.8VWF, SELP, FGA, FGF2

Publications for Intermittent Claudication

About this section

Articles related to Intermittent Claudication:

(show top 50)    (show all 536)
idTitleAuthorsYear
1
Effect of diabetes on the cutaneous microcirculation of the feet in patients with intermittent claudication. (25335813)
2014
2
Role of the latest endovascular technology in the treatment of intermittent claudication. (25018633)
2014
3
Modes of exercise training for intermittent claudication. (24993079)
2014
4
Vascular Reactivity Is Impaired and Associated With Walking Ability in Patients With Intermittent Claudication. (25100750)
2014
5
Exercise prescription using the heart of claudication pain onset in patients with intermittent claudication. (23917662)
2013
6
Education and home based training for intermittent claudication: functional effects and quality of life. (24177266)
2013
7
Comparison of two treadmill training programs on walking ability and endothelial function in intermittent claudication. (23117015)
2013
8
Authors' reply: systematic review of thea88efficacya88ofa88cilostazol,a88naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638). (24227373)
2013
9
Medical comorbidities but not interventions adversely affect survival in patients with intermittent claudication. (23972525)
2013
10
Free-living physical activity as a novel outcome measure in patients with intermittent claudication. (23265683)
2013
11
X-stop versus decompressive surgery for lumbar neurogenic intermittent claudication: randomized controlled trial with 2-year follow-up. (23403549)
2013
12
Vasculitides as a rare cause of intermittent claudication. (23731050)
2013
13
Randomized clinical trial of a brief psychological intervention to increase walking in patients with intermittent claudication. (22038532)
2012
14
Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease. (22021102)
2012
15
Naftidrofuryl for intermittent claudication. (23235580)
2012
16
Alteration in angiogenic and anti-angiogenic forms of vascular endothelial growth factor-A in skeletal muscle of patients with intermittent claudication following exercise training. (22402934)
2012
17
Validation of the Dutch version of the VascuQol questionnaire and the Amsterdam Linear Disability Score in patients with intermittent claudication. (22083223)
2012
18
Noonan syndrome presenting with neurogenic intermittent claudication. (23807040)
2012
19
Effect of supervised exercise therapy for intermittent claudication in patients with diabetes mellitus. (22858162)
2012
20
Long-term effects of structured home-based exercise program on functional capacity and quality of life in patients with intermittent claudication. (21704786)
2011
21
Quality of life and functional status after revascularization or conservative treatment in patients with intermittent claudication. (21278180)
2011
22
Gait variability of patients with intermittent claudication is similar before and after the onset of claudication pain. (21450380)
2011
23
Is remote ischemic preconditioning triggered by intermittent claudication secondary to peripheral arterial disease responsible for preventing early mortality after coronary artery bypass surgery? (21172560)
2011
24
Evaluation of patient compliance, quality of life impact and cost-effectiveness of a "test in-train out" exercise-based rehabilitation program for patients with intermittent claudication. (21712607)
2011
25
Intermittent claudication: From its risk factors to its long-term prognosis in men. The Quebec Cardiovascular Study. (20101352)
2010
26
Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA). (20501489)
2010
27
Community trial of home-based exercise therapy for intermittent claudication. (19366815)
2009
28
Peripheral arterial disease and intermittent claudication: efficacy of short-term upper body strength training, dynamic exercise training, and advice to exercise at home. (20218480)
2009
29
Calf muscle hemoglobin oxygen saturation characteristics and exercise performance in patients with intermittent claudication. (18572363)
2008
30
Effect of upper- and lower-limb exercise training on circulating soluble adhesion molecules, hs-CRP and stress proteins in patients with intermittent claudication. (18226561)
2008
31
Prevalence of angina, myocardial infarction and intermittent claudication assessed by Rose Questionnaire among patients with Behcet's syndrome. (18270223)
2008
32
Association between ankle-brachial index and risk factor profile in patients newly diagnosed with intermittent claudication. (18296843)
2008
33
Cardiac risk reduction in patients with intermittent claudication. (17400485)
2007
34
The effects of prostaglandin E-1 in patients with intermittent claudication. (16787192)
2006
35
High-intensity interval training for intermittent claudication in a vascular rehabilitation program. (16737929)
2006
36
Intravascular ultrasound-guided creation of re-entry sites to improve intermittent claudication in patients with aortic dissection. (16784333)
2006
37
A preliminary study on the effects of exercising to maximum walking distance on platelet and endothelial function in patients with intermittent claudication. (16360327)
2006
38
Intermittent claudication. (17095782)
2006
39
Walking exercise in patients with intermittent claudication not well implemented in Dutch primary care. (15841062)
2005
40
Rapid foot and calf compression increases walking distance in patients with intermittent claudication: results of a randomized study. (15886663)
2005
41
Management options for patients with intermittent claudication. (15150459)
2004
42
Natural history of stenosis in the iliac arteries in patients with intermittent claudication undergoing clinical treatment. (15654487)
2004
43
Bilateral intermittent claudication and the aorta. (15042397)
2004
44
Effects of orally administered OP-1206 alpha-CD with loxoprofen-Na on walking dysfunction in the rat neuropathic intermittent claudication model. (12907137)
2003
45
Efficacy and safety of cilostazol, a novel phosphodiesterase inhibitor in patients with intermittent claudication. (15168999)
2003
46
Platelets' glycoproteins and their ligands in patients with intermittent claudication. (12865882)
2003
47
Management of intermittent claudication (Br J Surg 2002; 89: 529-31). (12296906)
2002
48
Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication. (11782701)
2001
49
Serum lipoproteins and hemostatic function in intermittent claudication. (8399080)
1993
50
Efficacy of low-molecular-weight heparin in the management of intermittent claudication. (1847026)
1991

Variations for Intermittent Claudication

About this section

Expression for genes affiliated with Intermittent Claudication

About this section
Expression patterns in normal tissues for genes affiliated with Intermittent Claudication

Search GEO for disease gene expression data for Intermittent Claudication.

Pathways for genes affiliated with Intermittent Claudication

About this section

Compounds for genes affiliated with Intermittent Claudication

About this section

Compounds related to Intermittent Claudication according to GeneCards/GeneDecks:

(show top 50)    (show all 74)
idCompoundScoreTop Affiliating Genes
1sarpogrelate hydrochloride4410.0HTR2A, SELP
2sarpogrelate29 4411.0HTR2A, SELP
3fucoidan449.8FGF2, SELP
4tetramethylpyrazine449.8VWF, SELP
5echistatin449.8SELP, VWF
6hydroxyethyl starch449.8SELP, VWF
7quinapril44 50 1211.8VWF, SELP
8tirofiban44 1210.8VWF, SELP
9ristocetin449.7VWF, SELP
10abciximab44 1210.7SELP, VWF
11batroxobin449.6SELP, FGA
12iohexol449.6FGA, SELP
13desmopressin44 60 29 1212.6SELP, VWF
14bivalirudin44 1210.6FGA, SELP
15yohimbine44 3 29 1212.6VWF, HTR2A
16argatroban44 1210.6SELP, FGA
17clopidogrel44 50 25 1212.6SELP, VWF
18ptca449.5FGA, SELP
19cuprophan449.5FGA, SELP
20sucralfate44 1210.5FGF2, FGA
21kininogen449.4VWF, SELP
22sodium chlorate449.4FGF2, SELP, VWF
236-ketoprostaglandin f1alpha449.4FGA, VWF
24dermatan sulfate449.3SELP, FGF2, VWF
25citrate449.3SELP, VWF, FGF2
26carbohydrates449.3SELP, FGF2, VWF
27amiloride44 29 1211.2SELP, FGF2
28protamine449.1FGA, SELP, FGF2
2911-dehydrothromboxane b2449.1VWF, SELP, FGA
30ppack449.1SELP, VWF, FGA
31ticlopidine44 1210.1SELP, VWF, FGA
32polysulfone449.1VWF, SELP, FGA
33hirudin449.1SELP, FGA, VWF
34txb2449.1VWF, SELP, FGA
35thromboxane44 2510.0VWF, SELP, FGA
36cyclosporin a44 29 6011.0SELP, FGF2, VWF
37thromboxane a244 2510.0SELP, VWF, FGA
38aprotinin44 1210.0FGA, SELP, VWF
39aspirin44 50 29 2512.0FGA, SELP, VWF
40epinephrine44 25 1210.9FGA, VWF, SELP
41fibrinogen448.9VWF, SELP, FGA
42histamine44 29 2510.9FGA, SELP, VWF
43pge2448.8FGF2, SELP, FGA
44lactate448.6VWF, FGA, SELP
45norepinephrine44 25 1210.6FGA, HTR2A, SELP, VWF
46dipyridamole44 60 29 1211.6FGA, FGF2, SELP, VWF
47warfarin44 50 25 1211.6SELP, FGF2, FGA, VWF
48prostacyclin448.5SELP, VWF, FGA, FGF2
49creatinine448.5FGA, SELP, VWF
50heparin44 29 25 1211.5SELP, FGF2, FGA, VWF

GO Terms for genes affiliated with Intermittent Claudication

About this section

Cellular components related to Intermittent Claudication according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1platelet alpha granule lumenGO:0310939.0FGA, VWF
2platelet alpha granuleGO:0310918.9FGA, VWF
3external side of plasma membraneGO:0098978.3FGA, SELP, VWF

Biological processes related to Intermittent Claudication according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1release of sequestered calcium ion into cytosolGO:0512099.5FGF2, HTR2A
2positive regulation of ERK1 and ERK2 cascadeGO:0703749.5FGF2, HTR2A
3platelet degranulationGO:0025768.7FGA, SELP, VWF
4platelet activationGO:0301688.7FGA, SELP, VWF
5extracellular matrix organizationGO:0301988.4VWF, FGA, FGF2
6blood coagulationGO:0075968.3FGA, SELP, VWF

Molecular functions related to Intermittent Claudication according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1heparin bindingGO:0082019.5FGF2, SELP
2glycoprotein bindingGO:0019489.3SELP, VWF
3protein N-terminus bindingGO:0474859.0PEX19, VWF

Products for genes affiliated with Intermittent Claudication

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies
  • Proteins
  • Kits and Assays

Sources for Intermittent Claudication

About this section
4CDC
14ExPASy
15FMA
23GTR
24HGMD
25HMDB
26ICD10
27ICD10 via Orphanet
28ICD9CM
29IUPHAR
30KEGG
34MeSH
35MESH via Orphanet
36MGI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
51PubMed
52QIAGEN
57SNOMED-CT via Orphanet
61UMLS
62UMLS via Orphanet